Cipla Q4 Results 2025: Net Profit Jumps 30% YoY; Dividend Declared of ₹16 Per Share

Cipla has announced its Q4 results for FY25 with a solid financial performance. The company has reported a 30.10% surge in consolidated net profit year-on-year, reaching ₹1,221.84 crore. Cipla’s share fell 1.33% or ₹20.20 today on 14th May 2025 to reach ₹1,499.90 per share. Scroll down to explore key highlights from the Cipla Q4 results 2025 report. 

Cipla Q4 Results 2025: Key Highlights

• Cipla has reported its consolidated net profit as ₹1,222.84 crore with a 30.10% surge on a YoY basis. 
• Revenue of Cipla gained more than 9% to reach ₹6,729.70 crore. 
• The company’s Sales revenue rose by 8.5% YoY to reach ₹6,597.72 crore against ₹6,082.37 crore in the corresponding quarter of the previous year. 
• Revenue from the new ventures of Cipla Limited increased by 35.44% YoY to reach ₹288.48 crore from ₹212.99 crore. 
• EBITDA of Cipla for the Q4FY25 jumped 17% YoY to reach ₹1,538 crore, while EBITDA margin increased 150 BPS YoY to 22.80%. 

Margin Headwinds and Product Transition

Cipla’s management has stated that new products will not completely compensate for the effect of the phasing out of Revlimid. This product is presently a robust contributor to Cipla’s US business. The margins are potentially squeezed up to 300 bps in FY27.

Cipla Share Dividend Declaration

Cipla has announced a final dividend of ₹13 per share for FY25 and a special dividend of ₹3 per share on the occasion of the drug firm completing 90 years. It takes the total dividend amount of Cipla shares to ₹16 per share of a face value of ₹2 each. 

Cipla Share Performance

Cipla share price reached ₹1,499.90, 1.33% lower or ₹20.20 down from its previous closing. Moreover, the stock has delivered 163.00% returns in the past 5 years. The 52-week high/low of Cipla shares is ₹1,702.05/₹1,335.00. 

Final Thoughts

Cipla has posted a robust financial performance in its Q4 results for the fiscal year ended 31st March 2025. With a significant growth in its revenue and net profitability, the company has displayed strong company fundamentals. Additionally, the company’s board has also announced a final dividend of ₹13 per share, demonstrating its commitment to reward shareholders. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities. 

Recent News Articles 

Hero Motocorp Q4 Results 2025: Standalone Profits Rise 6.4%; Revenue Beats Street Estimates; Rs 65 per share dividend declared.

Accretion Pharmaceuticals IPO GMP: Day 1 IPO Live Updates

Stock Market Today: Sensex Trades 350 Points Up; Nifty50 Jumps 0.46%

Stocks to Watch Today: 14th May 2025

Other News Articles

Accretion Pharmaceuticals IPO GMP & Review

RVNL Share surges 8% on Order Win Despite Weak Technics

Integrity Infrabuild Developers IPO GMP: Day 1

Sensex Trades 800 Points Down; Nifty50 Plunged 0.75%:

Stocks to Watch Today: 13th May 2025

Trent Ltd. Share Surges 4.5% Despite Dull Q4 Performance